ADA example [Bioanalytics]

posted by mittyri – Russia, 2019-03-18 23:20 (2129 d 14:37 ago) – Posting: # 20047
Views: 6,493

Hi Helmut,

Thank you so much for the detailed answer!

❝ ❝ Even in analytical methodology (say QC samples): isn't possible to handle that values (as they are) for example for the mean evaluation for some level of QC sample?


❝ Not sure what you mean here.


Sorry for incomplete/incorrect question.
Say ADA, getting cut-off point (IV B FDA)
What would be a best tactics for cut-off point selection?
Say the data of healthy volunteers is {100, BLOQ, BLOQ}


Edit: Guidance linked. [Helmut]

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,362 posts in 4,906 threads, 1,678 registered users;
141 visitors (0 registered, 141 guests [including 9 identified bots]).
Forum time: 13:57 CET (Europe/Vienna)

I have not failed 700 times. I have not failed once.
I have succeeded in proving
that those 700 ways will not work.    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5